Centerpoint Advisors’s Avidity Biosciences RNAM Stock Holding History

Centerpoint Advisors’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-50	Closed	-$4K	–	420
2025 Q4	$4K	Hold	50	–	–	﹤0.01%	366
2025 Q3	$2K	Hold	50	–	–	﹤0.01%	410
2025 Q2	$1K	Buy	+50	New	+$1.49K	﹤0.01%	375

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $158M AUM

Centerpoint Advisors's RNAM Position: Q1 2026 in Review

Centerpoint Advisors sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 50 shares — an estimated $4K sold.

Centerpoint Advisors first reported a position in RNAM in Q2 2025 and held it in 3 quarters. The position peaked at $4K in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

Centerpoint Advisors reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
Centerpoint Advisors sold 50 Avidity Biosciences shares in Q1 2026, an estimated $4K.
Centerpoint Advisors first reported a position in Avidity Biosciences in Q2 2025 and held it in 3 quarters.
Centerpoint Advisors's Avidity Biosciences position peaked at $4K in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Centerpoint Advisors's 13F filing for Q1 2026, filed 7 May 2026.